The Road to 2035: Will NGS Replace the PCR Market?
There's a lot of talk about Next-Generation Sequencing (NGS) being the "PCR killer," but in 2026, that couldn't be further from the truth. While NGS is great for looking at the *whole* genome, the Polymerase Chain Reaction Market remains the king of speed and cost-effectiveness for targeted testing. Why spend $1,000 and wait three days for an NGS run when a $20 PCR test can give you...
0 Commentarios 0 Acciones 37 Views 0 Vista previa